Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-10

Clinical Trial Update: The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis [Phase 4]

View source ↗

Summary

This Phase 4 trial update investigates whether interleukin-7 receptor gene polymorphism is associated with ulcerative colitis risk. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Ulcerative Colitis (UC) | Phase 4 | Status: COMPLETED